Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
| Actual shortage: | 212 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2706 (92%) | |
Discontinuation Reports |
300 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 298 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
362 (11%) |
|
Overdue reports |
85 (40%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALACYCLOVIR | 500MG | TABLET | Resolved | 2024-04-18 | 2024-09-19 | 225489 |
| TEVA-VALACYCLOVIR | 500MG | TABLET | Resolved | 2019-10-31 | 2020-03-05 | 97605 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2022-01-20 | 2022-06-16 | 153189 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2017-08-02 | 2018-03-13 | 18033 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2023-09-19 | 2023-10-26 | 204769 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2023-11-16 | 2024-03-28 | 210440 |
| TEVA-VALGANCICLOVIR | 450MG | TABLET | Resolved | 2023-04-27 | 2023-06-21 | 190683 |
| TEVA-VALSARTAN | 160MG | TABLET | Actual shortage | 2025-02-06 | 2025-02-28 | 249728 |
| TEVA-VALSARTAN | 40MG | TABLET | Resolved | 2021-04-22 | 2025-04-29 | 137930 |
| TEVA-VALSARTAN | 80MG | TABLET | Resolved | 2021-04-22 | 2025-04-29 | 137933 |
| TEVA-VALSARTAN | 160MG | TABLET | Resolved | 2021-04-22 | 2023-06-09 | 137936 |
| TEVA-VALSARTAN | 320MG | TABLET | Resolved | 2021-04-22 | 2025-04-29 | 137939 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Resolved | 2019-09-26 | 2025-04-25 | 94834 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Resolved | 2020-01-24 | 2025-04-25 | 104333 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Resolved | 2017-03-13 | 2018-05-11 | 1226 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Resolved | 2017-03-13 | 2017-10-10 | 1552 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Resolved | 2017-04-25 | 2018-02-21 | 8074 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Resolved | 2018-10-23 | 2025-04-29 | 65369 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Resolved | 2018-10-23 | 2025-04-25 | 65372 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Resolved | 2018-10-23 | 2025-04-25 | 65375 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133880 |
| ACT CELECOXIB | 200MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133874 |
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
| ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81418 |
| ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81381 |
| ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142915 |
| ACT DILTIAZEM CD | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142918 |
| ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142921 |
| TEVA-DILTIAZEM T | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115126 |
| TEVA-DILTIAZEM T | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115117 |
| TEVA-DILTIAZEM T | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115120 |
| TEVA-DILTIAZEM T | 240MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115123 |
| TEVA-DILTIAZEM T | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115114 |
| ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
| ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 |